ÂÜÀòÂÒÂ×

Catherine Hutt has been working in the clinical operations field since 1996. Catherine began their career at SciClone Pharmaceuticals as a Clinical Research Associate, and then moved to MedImmune in 2002 to take on the same role. In 2003, they joined Genentech as a Sr. Country Study Manager, and later became a Sr. Global Study Manager and Clinical Trial Manager. In 2021, they were hired as a Senior Clinical Study Manager at BeiGene, and is currently employed as an Associate Director of Clinical Operations at Faraday Pharmaceuticals, Inc.

Catherine Hutt has a Master's degree in Counseling Psychology from Notre Dame de Namur University and a Bachelor's degree in Psychology from California State University-Sacramento. Catherine also holds a certification in Adult and Pediatric First Aid/CPR/AED from the American Red Cross, which they obtained in August 2019.